HEADER TRANSPORT PROTEIN 10-MAY-23 8STE TITLE CRYO-EM STRUCTURE OF NKCC1 FU_CTD COMPND MOL_ID: 1; COMPND 2 MOLECULE: SOLUTE CARRIER FAMILY 12 MEMBER 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: NKCC1 FU_CTD; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SLC12A2; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS COTRANSPORTER, DIMER, ION, MEMBRANE PROTEIN, TRANSPORT PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR M.A.MOSENG REVDAT 2 31-MAY-23 8STE 1 REMARK REVDAT 1 17-MAY-23 8STE 0 JRNL AUTH M.A.MOSENG,C.C.SU,K.RIOS,M.CUI,M.LYU,P.GLAZA,P.A.KLENOTIC, JRNL AUTH 2 E.DELPIRE,E.W.YU JRNL TITL INHIBITION MECHANISM OF NKCC1 INVOLVES THE CARBOXYL TERMINUS JRNL TITL 2 AND LONG-RANGE CONFORMATIONAL COUPLING. JRNL REF SCI ADV V. 8 Q0952 2022 JRNL REFN ESSN 2375-2548 JRNL PMID 36306358 JRNL DOI 10.1126/SCIADV.ABQ0952 REMARK 2 REMARK 2 RESOLUTION. 3.34 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.340 REMARK 3 NUMBER OF PARTICLES : 304440 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING ONLY REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8STE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-MAY-23. REMARK 100 THE DEPOSITION ID IS D_1000274306. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : NKCC1_FU_CTD REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 5000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 4000.00 REMARK 245 ILLUMINATION MODE : OTHER REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 985 REMARK 465 ILE A 986 REMARK 465 SER A 987 REMARK 465 HIS A 988 REMARK 465 LEU A 989 REMARK 465 GLN A 990 REMARK 465 GLY A 991 REMARK 465 GLN A 992 REMARK 465 GLU A 993 REMARK 465 SER A 994 REMARK 465 LYS A 995 REMARK 465 GLY A 996 REMARK 465 PRO A 997 REMARK 465 ILE A 998 REMARK 465 VAL A 999 REMARK 465 PRO A 1000 REMARK 465 LEU A 1001 REMARK 465 ASN A 1002 REMARK 465 VAL A 1003 REMARK 465 ALA A 1004 REMARK 465 ASP A 1005 REMARK 465 GLN A 1006 REMARK 465 LYS A 1007 REMARK 465 LEU A 1008 REMARK 465 LEU A 1009 REMARK 465 GLU A 1010 REMARK 465 ALA A 1011 REMARK 465 SER A 1012 REMARK 465 THR A 1013 REMARK 465 GLN A 1014 REMARK 465 PHE A 1015 REMARK 465 GLN A 1016 REMARK 465 LYS A 1017 REMARK 465 LYS A 1018 REMARK 465 GLN A 1019 REMARK 465 GLY A 1020 REMARK 465 THR A 1209 REMARK 465 PHE A 1210 REMARK 465 ASP B 985 REMARK 465 ILE B 986 REMARK 465 SER B 987 REMARK 465 HIS B 988 REMARK 465 LEU B 989 REMARK 465 GLN B 990 REMARK 465 GLY B 991 REMARK 465 GLN B 992 REMARK 465 GLU B 993 REMARK 465 SER B 994 REMARK 465 LYS B 995 REMARK 465 GLY B 996 REMARK 465 PRO B 997 REMARK 465 ILE B 998 REMARK 465 VAL B 999 REMARK 465 PRO B 1000 REMARK 465 LEU B 1001 REMARK 465 ASN B 1002 REMARK 465 VAL B 1003 REMARK 465 ALA B 1004 REMARK 465 ASP B 1005 REMARK 465 GLN B 1006 REMARK 465 LYS B 1007 REMARK 465 LEU B 1008 REMARK 465 LEU B 1009 REMARK 465 GLU B 1010 REMARK 465 ALA B 1011 REMARK 465 SER B 1012 REMARK 465 THR B 1013 REMARK 465 GLN B 1014 REMARK 465 PHE B 1015 REMARK 465 GLN B 1016 REMARK 465 LYS B 1017 REMARK 465 LYS B 1018 REMARK 465 GLN B 1019 REMARK 465 GLY B 1020 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP B 1025 OG SER B 1160 1.98 REMARK 500 O ASP B 810 NZ LYS B 1046 2.06 REMARK 500 OD1 ASP A 901 OG SER A 1180 2.12 REMARK 500 OD2 ASP A 1025 OG SER A 1160 2.15 REMARK 500 ND2 ASN B 1100 OE2 GLU B 1154 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 761 -3.77 72.64 REMARK 500 ARG A 788 74.90 54.37 REMARK 500 ASP A1032 -96.62 53.68 REMARK 500 LYS A1047 -7.92 73.29 REMARK 500 GLU A1130 72.99 -161.50 REMARK 500 ASP A1193 45.69 -140.38 REMARK 500 PRO A1195 -179.95 -63.88 REMARK 500 HIS B 783 -114.73 56.95 REMARK 500 LYS B 785 34.76 -96.78 REMARK 500 ARG B 801 64.41 62.25 REMARK 500 ASN B 814 32.04 -140.89 REMARK 500 MET B 879 56.96 -95.67 REMARK 500 TRP B1027 78.06 -100.21 REMARK 500 PRO B1195 -175.33 -68.34 REMARK 500 LEU B1208 41.05 37.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-40759 RELATED DB: EMDB REMARK 900 CRYO-EM STRUCTURE OF NKCC1 FU_CTD DBREF1 8STE A 760 1210 UNP A0A8C9GPS0_9PRIM DBREF2 8STE A A0A8C9GPS0 758 1150 DBREF1 8STE B 760 1210 UNP A0A8C9GPS0_9PRIM DBREF2 8STE B A0A8C9GPS0 758 1150 SEQADV 8STE SER A 778 UNP A0A8C9GPS THR 776 CONFLICT SEQADV 8STE LYS A 1021 UNP A0A8C9GPS ARG 961 CONFLICT SEQADV 8STE ILE A 1107 UNP A0A8C9GPS MET 1047 CONFLICT SEQADV 8STE SER B 778 UNP A0A8C9GPS THR 776 CONFLICT SEQADV 8STE LYS B 1021 UNP A0A8C9GPS ARG 961 CONFLICT SEQADV 8STE ILE B 1107 UNP A0A8C9GPS MET 1047 CONFLICT SEQRES 1 A 393 SER SER THR GLN ALA LEU THR TYR LEU ASN ALA LEU GLN SEQRES 2 A 393 HIS SER ILE ARG LEU SER GLY VAL GLU ASP HIS VAL LYS SEQRES 3 A 393 ASN PHE ARG PRO GLN CYS LEU VAL MET THR GLY ALA PRO SEQRES 4 A 393 ASN SER ARG PRO ALA LEU LEU HIS LEU VAL HIS ASP PHE SEQRES 5 A 393 THR LYS ASN VAL GLY LEU MET ILE CYS GLY HIS VAL HIS SEQRES 6 A 393 MET GLY PRO ARG ARG GLN ALA MET LYS GLU MET SER ILE SEQRES 7 A 393 ASP GLN ALA LYS TYR GLN ARG TRP LEU ILE LYS ASN LYS SEQRES 8 A 393 MET LYS ALA PHE TYR ALA PRO VAL HIS ALA ASP ASP LEU SEQRES 9 A 393 ARG GLU GLY ALA GLN TYR LEU MET GLN ALA ALA GLY LEU SEQRES 10 A 393 GLY ARG MET LYS PRO ASN THR LEU VAL LEU GLY PHE LYS SEQRES 11 A 393 LYS ASP TRP LEU GLN ALA ASP MET ARG ASP VAL ASP MET SEQRES 12 A 393 TYR ILE ASN LEU PHE HIS ASP ALA PHE ASP ILE GLN TYR SEQRES 13 A 393 GLY VAL VAL VAL ILE ARG LEU LYS GLU GLY LEU ASP ILE SEQRES 14 A 393 SER HIS LEU GLN GLY GLN GLU SER LYS GLY PRO ILE VAL SEQRES 15 A 393 PRO LEU ASN VAL ALA ASP GLN LYS LEU LEU GLU ALA SER SEQRES 16 A 393 THR GLN PHE GLN LYS LYS GLN GLY LYS ASN THR ILE ASP SEQRES 17 A 393 VAL TRP TRP LEU PHE ASP ASP GLY GLY LEU THR LEU LEU SEQRES 18 A 393 ILE PRO TYR LEU LEU THR THR LYS LYS LYS TRP LYS ASP SEQRES 19 A 393 CYS LYS ILE ARG VAL PHE ILE GLY GLY LYS ILE ASN ARG SEQRES 20 A 393 ILE ASP HIS ASP ARG ARG ALA MET ALA THR LEU LEU SER SEQRES 21 A 393 LYS PHE ARG ILE ASP PHE SER ASP ILE MET VAL LEU GLY SEQRES 22 A 393 ASP ILE ASN THR LYS PRO LYS LYS GLU ASN ILE ILE ALA SEQRES 23 A 393 PHE GLU GLU ILE ILE GLU PRO TYR ARG LEU HIS GLU ASP SEQRES 24 A 393 ASP LYS GLU GLN ASP ILE ALA ASP LYS MET LYS GLU ASP SEQRES 25 A 393 GLU PRO TRP ARG ILE THR ASP ASN GLU LEU GLU LEU TYR SEQRES 26 A 393 LYS THR LYS THR TYR ARG GLN ILE ARG LEU ASN GLU LEU SEQRES 27 A 393 LEU LYS GLU HIS SER SER THR ALA ASN ILE ILE VAL MET SEQRES 28 A 393 SER LEU PRO VAL ALA ARG LYS GLY ALA VAL SER SER ALA SEQRES 29 A 393 LEU TYR MET ALA TRP LEU GLU ALA LEU SER LYS ASP LEU SEQRES 30 A 393 PRO PRO ILE LEU LEU VAL ARG GLY ASN HIS GLN SER VAL SEQRES 31 A 393 LEU THR PHE SEQRES 1 B 393 SER SER THR GLN ALA LEU THR TYR LEU ASN ALA LEU GLN SEQRES 2 B 393 HIS SER ILE ARG LEU SER GLY VAL GLU ASP HIS VAL LYS SEQRES 3 B 393 ASN PHE ARG PRO GLN CYS LEU VAL MET THR GLY ALA PRO SEQRES 4 B 393 ASN SER ARG PRO ALA LEU LEU HIS LEU VAL HIS ASP PHE SEQRES 5 B 393 THR LYS ASN VAL GLY LEU MET ILE CYS GLY HIS VAL HIS SEQRES 6 B 393 MET GLY PRO ARG ARG GLN ALA MET LYS GLU MET SER ILE SEQRES 7 B 393 ASP GLN ALA LYS TYR GLN ARG TRP LEU ILE LYS ASN LYS SEQRES 8 B 393 MET LYS ALA PHE TYR ALA PRO VAL HIS ALA ASP ASP LEU SEQRES 9 B 393 ARG GLU GLY ALA GLN TYR LEU MET GLN ALA ALA GLY LEU SEQRES 10 B 393 GLY ARG MET LYS PRO ASN THR LEU VAL LEU GLY PHE LYS SEQRES 11 B 393 LYS ASP TRP LEU GLN ALA ASP MET ARG ASP VAL ASP MET SEQRES 12 B 393 TYR ILE ASN LEU PHE HIS ASP ALA PHE ASP ILE GLN TYR SEQRES 13 B 393 GLY VAL VAL VAL ILE ARG LEU LYS GLU GLY LEU ASP ILE SEQRES 14 B 393 SER HIS LEU GLN GLY GLN GLU SER LYS GLY PRO ILE VAL SEQRES 15 B 393 PRO LEU ASN VAL ALA ASP GLN LYS LEU LEU GLU ALA SER SEQRES 16 B 393 THR GLN PHE GLN LYS LYS GLN GLY LYS ASN THR ILE ASP SEQRES 17 B 393 VAL TRP TRP LEU PHE ASP ASP GLY GLY LEU THR LEU LEU SEQRES 18 B 393 ILE PRO TYR LEU LEU THR THR LYS LYS LYS TRP LYS ASP SEQRES 19 B 393 CYS LYS ILE ARG VAL PHE ILE GLY GLY LYS ILE ASN ARG SEQRES 20 B 393 ILE ASP HIS ASP ARG ARG ALA MET ALA THR LEU LEU SER SEQRES 21 B 393 LYS PHE ARG ILE ASP PHE SER ASP ILE MET VAL LEU GLY SEQRES 22 B 393 ASP ILE ASN THR LYS PRO LYS LYS GLU ASN ILE ILE ALA SEQRES 23 B 393 PHE GLU GLU ILE ILE GLU PRO TYR ARG LEU HIS GLU ASP SEQRES 24 B 393 ASP LYS GLU GLN ASP ILE ALA ASP LYS MET LYS GLU ASP SEQRES 25 B 393 GLU PRO TRP ARG ILE THR ASP ASN GLU LEU GLU LEU TYR SEQRES 26 B 393 LYS THR LYS THR TYR ARG GLN ILE ARG LEU ASN GLU LEU SEQRES 27 B 393 LEU LYS GLU HIS SER SER THR ALA ASN ILE ILE VAL MET SEQRES 28 B 393 SER LEU PRO VAL ALA ARG LYS GLY ALA VAL SER SER ALA SEQRES 29 B 393 LEU TYR MET ALA TRP LEU GLU ALA LEU SER LYS ASP LEU SEQRES 30 B 393 PRO PRO ILE LEU LEU VAL ARG GLY ASN HIS GLN SER VAL SEQRES 31 B 393 LEU THR PHE HET FUN A1301 21 HET FUN B1301 21 HETNAM FUN 5-(AMINOSULFONYL)-4-CHLORO-2-[(2-FURYLMETHYL) HETNAM 2 FUN AMINO]BENZOIC ACID HETSYN FUN FUROSEMIDE FORMUL 3 FUN 2(C12 H11 CL N2 O5 S) HELIX 1 AA1 GLN A 763 VAL A 780 1 18 HELIX 2 AA2 ARG A 801 THR A 812 1 12 HELIX 3 AA3 GLN A 830 ASN A 849 1 20 HELIX 4 AA4 ASP A 862 ALA A 874 1 13 HELIX 5 AA5 ASP A 896 ILE A 913 1 18 HELIX 6 AA6 GLY A 1034 THR A 1045 1 12 HELIX 7 AA7 ARG A 1064 ARG A 1080 1 17 HELIX 8 AA8 LYS A 1097 GLU A 1109 1 13 HELIX 9 AA9 PRO A 1110 ARG A 1112 5 3 HELIX 10 AB1 GLU A 1119 GLU A 1130 1 12 HELIX 11 AB2 THR A 1135 TYR A 1142 1 8 HELIX 12 AB3 TYR A 1142 SER A 1160 1 19 HELIX 13 AB4 SER A 1179 SER A 1191 1 13 HELIX 14 AB5 GLN B 763 VAL B 780 1 18 HELIX 15 AB6 ARG B 801 PHE B 811 1 11 HELIX 16 AB7 GLN B 830 ASN B 849 1 20 HELIX 17 AB8 ASP B 862 ALA B 874 1 13 HELIX 18 AB9 ASP B 896 ILE B 913 1 18 HELIX 19 AC1 GLY B 1034 THR B 1045 1 12 HELIX 20 AC2 ARG B 1064 ARG B 1080 1 17 HELIX 21 AC3 LYS B 1097 ILE B 1108 1 12 HELIX 22 AC4 GLU B 1119 GLU B 1130 1 12 HELIX 23 AC5 ASP B 1136 TYR B 1142 1 7 HELIX 24 AC6 TYR B 1142 SER B 1160 1 19 HELIX 25 AC7 SER B 1179 SER B 1191 1 13 SHEET 1 AA110 ALA A 853 HIS A 859 0 SHEET 2 AA110 MET A 818 HIS A 824 1 N CYS A 820 O ALA A 856 SHEET 3 AA110 CYS A 791 MET A 794 1 N CYS A 791 O ILE A 819 SHEET 4 AA110 THR A 883 GLY A 887 1 O VAL A 885 N MET A 794 SHEET 5 AA110 GLY A 916 ARG A 921 1 O VAL A 918 N LEU A 884 SHEET 6 AA110 ILE A1197 ARG A1201 -1 O LEU A1199 N VAL A 919 SHEET 7 AA110 ILE A1166 SER A1169 1 N MET A1168 O VAL A1200 SHEET 8 AA110 THR A1023 TRP A1027 1 N TRP A1027 O VAL A1167 SHEET 9 AA110 LYS A1053 GLY A1059 1 O PHE A1057 N VAL A1026 SHEET 10 AA110 ILE A1086 LEU A1089 1 O LEU A1089 N ILE A1058 SHEET 1 AA2 8 CYS B 791 VAL B 793 0 SHEET 2 AA2 8 THR B 883 GLY B 887 1 O THR B 883 N LEU B 792 SHEET 3 AA2 8 GLY B 916 ILE B 920 1 O GLY B 916 N LEU B 884 SHEET 4 AA2 8 ILE B1197 ARG B1201 -1 O LEU B1199 N VAL B 919 SHEET 5 AA2 8 ILE B1165 SER B1169 1 N MET B1168 O VAL B1200 SHEET 6 AA2 8 ILE B1024 TRP B1027 1 N ASP B1025 O VAL B1167 SHEET 7 AA2 8 ILE B1054 GLY B1059 1 O PHE B1057 N VAL B1026 SHEET 8 AA2 8 ASP B1085 LEU B1089 1 O MET B1087 N VAL B1056 SHEET 1 AA3 2 MET B 818 ILE B 819 0 SHEET 2 AA3 2 ALA B 853 PHE B 854 1 O PHE B 854 N MET B 818 SHEET 1 AA4 2 HIS B 822 HIS B 824 0 SHEET 2 AA4 2 PRO B 857 HIS B 859 1 O VAL B 858 N HIS B 824 SHEET 1 AA5 2 ARG B1112 LEU B1113 0 SHEET 2 AA5 2 ILE B1134 THR B1135 1 O ILE B1134 N LEU B1113 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000